U.S. FDA approves Sanofi's Gaucher disease drug Cerdelga
August 19, 2014 at 17:29 PM EDT
Aug 19 (Reuters) - The U.S. Food and Drug Administration said on Tuesday it has approved Sanofi SA's drug Cerdelga to treat patients with type 1 Gaucher disease, a rare genetic disorder.
